Clinical Trials
3 trialsNCT02334735 2022-09-15
A Comparison of Matured Dendritic Cells and MontanideĀ® in Study Subjects With High Risk of Melanoma Recurrence
Icahn School of Medicine at Mount Sinai
Phase 2 Completed
NCT01876212 2019-08-22
Dendritic Cell Vaccines + Dasatinib for Metastatic Melanoma
University of Pittsburgh
Phase 2 Completed
NCT00978913 2015-08-19
Transfected Dendritic Cell Based Therapy for Patients With Breast Cancer or Malignant Melanoma
Herlev Hospital
Phase 1 Completed